TCIM
ATNM icon

TIAA CREF Investment Management’s Actinium Pharmaceuticals ATNM Stock Holding History

TIAA CREF Investment Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,819
Closed -$304K – 3105
2015
Q2 		$304K Buy
3,819
+185
+5% +$15.8K ﹤0.01% 3068
2015
Q1 		$269K Buy
3,634
+21
+0.6% +$2.5K ﹤0.01% 3027
2014
Q4 		$638K Buy
3,613
+50
+1% +$9.49K ﹤0.01% 2878
2014
Q3 		$716K Buy
3,563
+148
+4% +$29.4K ﹤0.01% 2819
2014
Q2 		$740K Buy
+3,415
New +$1.14M ﹤0.01% 2891

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return